Copart announced that CEO Jeff Liaw will step down on July 31, 2026, coinciding with an investigation by Pomerantz LLP into possible securities fraud and unlawful practices involving the company and its officers. Following the announcement, Copart's stock price fell by 8.02% to $28.10 per share. The investigation could lead to legal action and impacts investor confidence in Copart's leadership and governance. Investors are advised to contact Pomerantz LLP for more information about joining a class action lawsuit.
Idaho Copper Corporation announced an $18 million public offering of common stock and warrants priced at $4.85 per share, with an additional 45-day option for over-allotments. The proceeds will fund an updated Preliminary Economic Assessment, initial...
The global neonatal infant care market, valued at $3.06 billion in 2025, is projected to grow to $5.59 billion by 2035 at a CAGR of 6.21%. Growth is driven by increasing preterm births and neonatal complications like respiratory disorders and jaundic...
The FDA has approved Casgevy, a gene therapy using CRISPR technology, for children aged 2 and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). This therapy modifies patients' own stem cells to increase fetal hemo...
Guggenheim Investments declared distributions for multiple closed-end funds, including Advent Convertible Income Fund and Guggenheim Strategic Opportunities Fund, with payments scheduled for July 31, 2026. These distributions may include income, capi...
AI/R Avenue Code, a subsidiary of AI/R, has achieved Google's Gemini Enterprise competency, recognizing its expertise in deploying advanced AI solutions securely in enterprises. This certification highlights their strengths in security, workflow auto...
